Likarda

?? In Case You Missed It: Imagine a world where therapies deliver the right dose at the right time, improving effectiveness and reducing side effects. This future is closer than you think. In our latest blog post, Jordan Hunt explores how controlled delivery systems are reshaping biologics, making treatments more precise, sustainable, and patient-friendly. At Likarda, we're using hydrogel encapsulation technology to take controlled delivery to the next level—offering smarter solutions for complex therapies. Curious about what this could mean for the future of healthcare? Read the full post: https://bit.ly/4hvXtcU #HealthcareInnovation #CellAndGeneTherapy #CellDelivery #Biologics

?? In Case You Missed It: If you couldn’t join us live, don’t worry—you can still catch all the insights from our latest webinar: "Advances in Hormone Therapy". Dr. Charles Virden and Dr. Lisa Stehno-Bittel dove into groundbreaking innovations in hormone replacement therapy, sharing how new technologies are transforming patient care and outcomes. Moderated by Dr. Stella K. Vnook, this session provides practical knowledge and the latest research advancements you won't want to miss. Watch the full recording now to stay informed and discover how these developments could impact the future of healthcare: https://bit.ly/4faSDjI #hormonetherapy #hormonereplacement #hormonetechnology #healthcareinnovation

Are you attending Advanced Therapies USA this week? If so, let’s connect! Likarda's CEO, Dr. Stella K. Vnook, and Chief Commercial Officer, Shelly Adams, will be there to discuss how our patented hydrogel technology can elevate the success, delivery, storage, and transportation of your therapies. Be sure to join us for Stella’s talk on Tuesday, November 12th, at 5 pm: “Innovating Cell Therapy Delivery: Potential Pathways for Enhanced Regulatory and Patient Outcomes.” It’s a must-attend for anyone committed to advancing cell therapies. We’d love to meet—reach out via the conference app or email us at [email protected]. Looking forward to seeing you there! #adtherapiesUSA #advancedtherapies #cellandgenetherapy #biotechstartup

This Diabetes Awareness Month, we're focusing on real solutions. Living with diabetes goes beyond managing blood sugar—it’s a constant challenge that impacts every aspect of life. The burden can feel overwhelming, from daily insulin injections ?? and frequent blood sugar monitoring ?? to meal planning and stress management. For many, the goal isn’t just survival. It’s achieving a better quality of life. ?? That’s where cell therapies come in. At Likarda, we’re working to reduce the need for daily management and improve long-term outcomes. In our recent webinar, experts explored how encapsulated cell therapies could transform diabetes care by enhancing insulin production and reducing reliance on external treatments. This approach brings new hope by focusing on restoring function, not just managing symptoms. This Diabetes Awareness Month, we reflect on the challenges people with diabetes face, and explore how science and innovation can help bring them closer to a life with fewer limitations. ?? Missed the webinar? Watch it here: https://bit.ly/4ftn9Fc #diabetes #diabetestreatment #diabetesinnovation

In an extremely competitive contest,?Jordan R. Hunt, PhD won the 2024 Likarda Soup-Off. The coveted Golden Ladle trophy was bestowed upon Mr. Hunt by the 2023 winner, Stephen Harrington. Congratulations Jordan. The soup was delicious.

It was great to provide the leaders of VitalTE LifeSciences Inc with a tour of Likarda's labs and to show them their encapsulated product. Dr. Charles Virden, Matt Virden and Michelle Mays are great people to work with and are bringing exciting new innovations to healthcare. Check them out.

Our President and Founder, Lisa Stehno-Bittel, had such fun hosting the VitalTE team at the Monday night Chief's game. Great game and great people to share it with.

The last CryoChats? entitled: 'Cryopreservation of Cell Aggregates and Spheroids', included featured panelist Lisa Stehno-Bittel. Listen to her introduction about the innovative work they do at Likarda. Don't miss next months CryoChats?, 'The Last 100 Yards: Cell and Gene Therapy Clinical Considerations', on Wednesday, December 4th at 2pm ET! ?? Registration is now open: https://lnkd.in/gUXVHa83 Dominic Clarke, Marty Giedlin, PhD, Jeffrey D. Allen, John Baust, Marc J. Centrella, Scott Fisher, John Bonham-Carter, Mike O'Mara, Priya Baraniak, Ph.D., Russ Straate, Aby J. Mathew, PhD, Adam Joules, Bill Ward, Narayan Bhagroo, Austin Bigley, Dalip Sethi, PhD, MBA, Allison Hubel, PhD, Advitiya Mahajan, Troy Louwagie #Cryopreservation #Biotechnology #ResearchAndDevelopment #CellTherapy #EviaBio #celltherapy #LifeScience

Our CEO, Stella K. Vnook was recently featured in a great read by The Medicine Maker on the future of #cryopreservation in cell and gene therapies. Stella joins other experts to discuss how this technology is transforming healthcare, from advanced therapies to potential space exploration. Cryopreservation plays a critical role in preserving the viability of life-saving treatments, ensuring they reach patients safely and efficiently, and Likarda's work with hydrogels is playing a large part in the advancement of this technology in real time. We’re grateful for the opportunity to contribute to this important conversation and look forward to having many more. ?? Check out the full article: https://bit.ly/4hxL0oS #Biotechnology #CellTherapies #HealthcareInnovation